🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA June 2026 enforcement update — compounding pharmacies Page 15

FDA June 2026 enforcement update — compounding pharmacies

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 366 replies 55,812 viewsPage 15 of 20
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Apr 14, 2025 at 4:18 PM#71

Old thread, but it comes up first when you search for this, so it is worth updating. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Last edited: Apr 14, 2025 at 6:18 PM
10 10labquiet_amy, emily_PDX, Dr.SleepRoch and 7 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Apr 22, 2025 at 6:05 AM#72
kate.chem said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Last edited: Apr 22, 2025 at 10:05 AM
9 9tom_AK, josh_phd_bmore, roxy_nash and 6 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Apr 29, 2025 at 7:48 PM#73
kate.chem said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Bookmarking. The distinction being drawn above is the one nobody else makes.

8 8BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
May 7, 2025 at 9:27 AM#74

From the other side of the consultation, briefly. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Correct me if the detail matters more than I have assumed.

7 7Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 4 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
May 14, 2025 at 11:01 PM#75
Dr.EndoEP said:
It helps to ask what evidence would change your mind before you look at any.

Same experience, arrived at from the opposite direction.

6 6emma_london, tammy_FL, Dr.LipidDallas and 3 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register